Skip to main content
Top
Literature
1.
go back to reference Asakura K, Ogata H, Omatsu M, Yamamoto M, Yoshida K, Ito H. A case of nephrogenic diabetes insipidus likely caused by anti-neutrophil cytoplastic antibody-associated vasculitis. CEN Case Rep. 2023;12(2):189–94.CrossRefPubMed Asakura K, Ogata H, Omatsu M, Yamamoto M, Yoshida K, Ito H. A case of nephrogenic diabetes insipidus likely caused by anti-neutrophil cytoplastic antibody-associated vasculitis. CEN Case Rep. 2023;12(2):189–94.CrossRefPubMed
2.
go back to reference Jennette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 657. Jennette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 657.
3.
go back to reference Ogawa Y, Kushida Y, Shimizu A, Joh K, Nagata M, Honda K. Kidney biopsy-atlas and text. 2nd ed. Tokyo: Tokyo Igakusha; 2017. p. 264. Ogawa Y, Kushida Y, Shimizu A, Joh K, Nagata M, Honda K. Kidney biopsy-atlas and text. 2nd ed. Tokyo: Tokyo Igakusha; 2017. p. 264.
4.
go back to reference Ogawa Y, Kushida Y, Shimizu A, Joh K, Nagata M, Honda K. Kidney biopsy-atlas and text. 2nd ed. Tokyo: Tokyo Igakusha; 2017. p. 290–309. Ogawa Y, Kushida Y, Shimizu A, Joh K, Nagata M, Honda K. Kidney biopsy-atlas and text. 2nd ed. Tokyo: Tokyo Igakusha; 2017. p. 290–309.
5.
go back to reference Iványi B, Hamilton-Dutoit SJ, Hansen HE, Olsen S. Acute tubulointerstitial nephritis: phenotype of infiltrating cells and prognostic impact of tubulitis. Virchows Arch. 1996;428(1):5–12.CrossRefPubMed Iványi B, Hamilton-Dutoit SJ, Hansen HE, Olsen S. Acute tubulointerstitial nephritis: phenotype of infiltrating cells and prognostic impact of tubulitis. Virchows Arch. 1996;428(1):5–12.CrossRefPubMed
6.
go back to reference Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: acute interstitial nephritis. Am J Kidney Dis. 2016;67(6):e35–6.CrossRefPubMed Fogo AB, Lusco MA, Najafian B, Alpers CE. AJKD atlas of renal pathology: acute interstitial nephritis. Am J Kidney Dis. 2016;67(6):e35–6.CrossRefPubMed
7.
go back to reference Jennette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 335. Jennette JC, Olson JL, Schwartz MM, Silva FG. Heptinstall’s pathology of the kidney. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. p. 335.
8.
go back to reference Ohara Y, Kobayashi N, Toda T, Matsui N. Renal infiltration of peripheral T cell lymphoma, not otherwise specified, mimicking drug-induced acute interstitial nephritis. CEN Case Rep. 2023;12(2):146–51.CrossRefPubMed Ohara Y, Kobayashi N, Toda T, Matsui N. Renal infiltration of peripheral T cell lymphoma, not otherwise specified, mimicking drug-induced acute interstitial nephritis. CEN Case Rep. 2023;12(2):146–51.CrossRefPubMed
Metadata
Title
Tubulointerstitial nephritis as a rare manifestation of ANCA-associated vasculitis: the challenge for its diagnosis and classification
Author
Tomoki Taniguchi
Publication date
22-05-2023
Publisher
Springer Nature Singapore
Published in
CEN Case Reports / Issue 1/2024
Electronic ISSN: 2192-4449
DOI
https://doi.org/10.1007/s13730-023-00799-2

Other articles of this Issue 1/2024

CEN Case Reports 1/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.